Published 51 minutes ago • loading... • Updated 10 minutes ago
Antimicrobial Resistance: WHO Notes Progress but Calls for Increased Efforts
The World Health Organization reported on November 16 that while more countries have adopted plans to combat antimicrobial resistance , most are failing to fund them, leaving the world off pace to meet critical 2030 targets.
Of 183 countries surveyed, 173 now have national action plans, up from 79 in 2017; however, only 42 countries have plans that are fully financed, implemented, and monitored, according to the WHO.
Only 36% of countries possess laboratory capabilities to test for resistance in all bacteria and fungi monitored by the WHO, falling well short of the 80% target set for 2030.
To address diagnostic gaps, the WHO released two toolkits to strengthen capacity, while acting director Jean-Pierre Nyemazi warned that "procedures we now take for granted become far riskier when antibiotics and antimicrobials no longer work."
Drug-Resistant infections could contribute to more than 39 million deaths worldwide over the next 25 years, as 2021 data showed AMR was directly responsible for one million deaths and linked to 4.7 million others.
Bacteria have long developed resistance to drugs designed to fight them, making many molecules ineffective. A total of 39 million deaths could be attributed to antimicrobial resistance by 2050.
The spread of antimicrobial resistance (AMR) is threatening modern medicine, despite progress in the fight against drug-resistant bacteria, senior World Health Organization (WHO) officials warned on Monday.
Cancer patients and people with chronic diseases face greater risks from infections caused by bacteria, viruses or fungi that no longer respond to available treatments.